Completed Access to Information Requests

About this information

Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).

If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.

*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.

Download datasets of the summaries of completed access to information requests.

Report Type

Organization

Disposition

Year

Month

Found 72834 record(s)

Req # A-2020-000051

Adverse Reaction Report (AER) for ENTYVIO. Report numbers: E2B_02968814, E2B_02935743, E2B_02935720, E2B_02980774, E2B_02928576, E2B_02931979, E2B_02928948, E2B_02971530, E2B_02982966, E2B_02935644, E2B_02955576, E2B_02987178.

Organization: Health Canada

182 page(s)
June 2020

Req # A-2020-000052

Adverse Reaction Report (AER) for VEDOLIZUMAB. Report numbers: E2B_02959635, E2B_02972254, E2B_02931989, E2B_02965282, E2B_02983115, E2B_02973212, E2B_02940189, E2B_02975948, E2B_02928892.

Organization: Health Canada

120 page(s)
June 2020

Req # A-2020-000087

Adverse Reaction Report (AER). Report number: 000730668.

Organization: Health Canada

8 page(s)
June 2020

Req # A-2020-000190

Adverse Reaction Report (AER) for Teriflunomide. Report number: E2B_02548709.

Organization: Health Canada

6 page(s)
June 2020

Req # A-2020-000093

Adverse Reaction Report (AER) for HYDROXYCHLOROQUINE SULFATE. Report numbers: E2B_02732621, E2B_02732642, E2B_02743629, E2B_02755293, E2B_02743830, E2B_02760135, E2B_02745999, E2B_02689032, E2B_02748963, E2B_02749663, E2B_02694913, E2B_02755340,…

Organization: Health Canada

226 page(s)
June 2020

Req # A-2020-000098

Adverse Reaction Report (AER) for HYDROXYCHLOROQUINE SULFATE. Report numbers: E2B_02938064, E2B_02938254, E2B_02902613, E2B_02902662, E2B_02902504, E2B_02902540, E2B_02902753, E2B_02902509, E2B_02903041, E2B_02901919, E2B_02947663, E2B_02949936,…

Organization: Health Canada

501 page(s)
June 2020

Req # A-2020-000112

Adverse Reaction Report (AER) for Cipralex® (escitalopram). Report number: E2B_02961876.

Organization: Health Canada

13 page(s)
June 2020

Req # A-2020-000127

Adverse Reaction Report (AER). Report numbers: E2B_02868934, E2B_02871948, E2B_02874537, E2B_02875447.

Organization: Health Canada

68 page(s)
June 2020

Req # A-2020-000133

Adverse Reaction Report (AER). Report number: 000735507.

Organization: Health Canada

6 page(s)
June 2020

Req # A-2020-000166

Adverse Reaction Report (AER) for botulinum toxin A. Report number: E2B_02938575.

Organization: Health Canada

6 page(s)
June 2020
Date modified: